Brentuximab vedotin in the treatment of CD30+ PTCL-Reference-Cited by-同舟云学术

Brentuximab vedotin in the treatment of CD30+ PTCL

Published:2019-12-26 Issue:26 Volume:134 Page:2339-2345
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Barta Stefan K.¹,Gong Jerald Z.²,Porcu Pierluigi³^ORCID

Affiliation:

1. Division of Hematology-Oncology, Perelman School of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;

2. Division of Hematopathology, Department of Pathology, Thomas Jefferson University, Philadelphia, PA; and

3. Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Philadelphia, PA

Abstract

In this timely Blood Spotlight, Barta et al summarize for the practicing hematologist the strengths and limitations of current data on brentuximab vedotin–based treatment in peripheral T-cell lymphoma (PTCL).

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/26/2339/1549667/bloodbld2019001821c.pdf

Reference58 articles.

1. Aggressive T-cell lymphomas: 2019 updates on diagnosis, risk stratification, and management;Zain;Am J Hematol,2019

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

3. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States;Abouyabis;Leuk Lymphoma,2008

4. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network;Herrera;Cancer,2014

5. Analysis of peripheral T-cell lymphoma diagnostic workup in the United States;Hsi;Clin Lymphoma Myeloma Leuk,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. How I treat peripheral T-cell lymphomas;Russian journal of hematology and transfusiology;2024-03-19

3. Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Non-Hodgkin Lymphoma as a Rare Differential Diagnosis of Lung Cancer: A Case Report;Cureus;2024-02-29

4. Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma;European Journal of Dermatology;2023-06

5. Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies;Cancers;2023-04-28